These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21441960)

  • 61. Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium.
    Treister N; Chai X; Kurland B; Pavletic S; Weisdorf D; Pidala J; Palmer J; Martin P; Inamoto Y; Arora M; Flowers M; Jacobsohn D; Jagasia M; Arai S; Lee SJ; Cutler C
    Bone Marrow Transplant; 2013 Aug; 48(8):1123-8. PubMed ID: 23353804
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genomic instability after allogeneic hematopoietic cell transplantation is frequent in oral mucosa, particularly in patients with a history of chronic graft-versus-host disease, and rare in nasal mucosa.
    Khan FM; Sy S; Louie P; Ugarte-Torres A; Berka N; Sinclair GD; Stewart DA; Russell JA; Storek J
    Blood; 2010 Sep; 116(10):1803-6. PubMed ID: 20548092
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Salivary flow rate, subjective oral dryness and dental caries 5 years after haematopoietic cell transplantation.
    Bulthuis MS; van Gennip LLA; Thomas RZ; van Leeuwen SJM; Bronkhorst EM; Laheij AMGA; Raber-Durlacher JE; Blijlevens NMA; Huysmans MDNJM
    BMC Oral Health; 2024 Sep; 24(1):1058. PubMed ID: 39256697
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Oral chronic graft versus host disease, what is it and how is it treated?].
    Laheij AMGA; Raber-Durlacher JE; Hazenberg MD; Schoordijk MCE; Huysmans MCDNJM; de Visscher JGAM
    Ned Tijdschr Tandheelkd; 2022 Jul; 129(7-8):329-336. PubMed ID: 35833281
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oral graft-versus-host disease.
    Imanguli MM; Alevizos I; Brown R; Pavletic SZ; Atkinson JC
    Oral Dis; 2008 Jul; 14(5):396-412. PubMed ID: 18593456
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MASCC/ISOO Clinical Practice Statement: The risk of secondary oral cancer following hematopoietic cell transplantation.
    Raber-Durlacher JE; Treister NS; Zadik Y; Dean DR; Miranda-Silva W; Fregnani ER; Epstein JB; Elad S
    Support Care Cancer; 2024 Jul; 32(8):545. PubMed ID: 39048762
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oral Chronic Graft-versus-Host Disease and Oral Health after Allogeneic Hematopoietic Cell Transplantation - What the Care Team Needs to Know.
    Laheij AMGA; Fregnani ER; de Macedo LD; Treister NS
    Transplant Cell Ther; 2024 Sep; 30(9S):S548-S558. PubMed ID: 39370236
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Endocrine complications in long-term survivors after allogeneic stem cell transplant.
    Gunasekaran U; Agarwal N; Jagasia MH; Jagasia SM
    Semin Hematol; 2012 Jan; 49(1):66-72. PubMed ID: 22221786
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oral chronic graft-versus-host disease: What the general dental practitioner needs to know.
    Haverman TM; Raber-Durlacher JE; Raghoebar II; Rademacher WMH; Rozema FR; Hazenberg MD; Epstein JB; Treister NS
    J Am Dent Assoc; 2020 Nov; 151(11):846-856. PubMed ID: 33121606
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oral complications of pediatric hematopoietic cell transplantation: diagnosis and management.
    Majorana A; Schubert MM; Porta F; Ugazio AG; Sapelli PL
    Support Care Cancer; 2000 Sep; 8(5):353-65. PubMed ID: 10975684
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Salivary BPIFA proteins are altered in patients undergoing hematopoietic cell transplantation.
    Innocentini LMAR; Silva AA; Carvalho MA; Coletta RD; Corrêa MEP; Bingle L; Bingle CD; Vargas PA; Lopes MA
    Oral Dis; 2022 May; 28(4):1279-1288. PubMed ID: 33682222
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MASCC/ISOO Clinical Practice Statement: Management of oral manifestations of chronic graft-versus-host-disease.
    Zadik Y; Raber-Durlacher JE; Epstein JB; Majorana A; Laheij A; Bardellini E; Blijlevens N; Elad S
    Support Care Cancer; 2024 Jul; 32(8):546. PubMed ID: 39048807
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fertility preservation in young patients before allogeneic haematopoietic SCT.
    Bastings L; Westphal JR; Beerendonk CC; Braat DD; Peek R
    Bone Marrow Transplant; 2012 Feb; 47(2):313-4. PubMed ID: 22120985
    [No Abstract]   [Full Text] [Related]  

  • 74. Identification of oral risk factors for chronic graft versus host disease in haematological patients who underwent allogeneic haematopoietic stem cell transplantation.
    Picardi A; Miranda M; Liciani F; Paterno G; Arcese W; Bollero P
    Oral Implantol (Rome); 2017; 10(4):390-397. PubMed ID: 29682256
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Current attitudes to the elimination of infection foci from the oral cavity of adult patients qualified for allogeneic hematopoietic stem cell transplantation].
    Bogusławska-Kapała A; Struzycka I; Hałaburda K
    Pol Merkur Lekarski; 2013 Nov; 35(209):305-8. PubMed ID: 24575654
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The experience of dysgeusia in allogeneic haematopoietic cell transplantation survivors: a qualitative study.
    Bomben D; Bin A; Venturini M; Bulfone T; Ghirotto L; Bressan V
    Support Care Cancer; 2019 Dec; 27(12):4607-4613. PubMed ID: 30937598
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Taste and smell disturbances in patients with chronic oral graft vs. host disease: An observational study.
    Boor M; Raber-Durlacher JE; Hazenberg MD; Rozema FR; Laheij AMGA
    Front Oral Health; 2022; 3():934607. PubMed ID: 36160117
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pre-transplant and longitudinal changes in faecal microbiome characteristics are associated with subsequent development of chronic graft-versus-host disease.
    El Jurdi N; Holtan SG; Hoeschen A; Velguth J; Hillmann B; Betts BC; MacMillan ML; Weisdorf DJ; Khoruts A; Rashidi A; Shields-Cutler R
    Br J Haematol; 2023 Oct; 203(2):288-294. PubMed ID: 37553783
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of xerostomia in hematopoietic cell transplantation by a simple capacitance method device.
    Sugiura Y; Soga Y; Nishide S; Kono K; Takahashi K; Fujii N; Ishimaru F; Tanimoto M; Nishimura F; Takashiba S
    Support Care Cancer; 2008 Oct; 16(10):1197-200. PubMed ID: 18528713
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oral Chronic Graft-Versus-Host Disease.
    Dean D; Sroussi H
    Front Oral Health; 2022; 3():903154. PubMed ID: 35719318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.